Literature DB >> 10608419

Respiratory viruses and asthma.

R S Peebles1, T V Hartert.   

Abstract

Viral infections have become increasingly recognized as a significant cause of asthma exacerbations, mainly because of improved viral detection techniques. Unfortunately, the ability to specifically treat viral infections and to limit the asthma morbidity associated with these agents has not kept pace with diagnostic technology. This article focuses on current concepts of the epidemiology of viruses in asthma exacerbations, investigations studying the physiologic and immunologic consequences of viral infection, and potential therapies to minimize virally-induced airway hyperresponsiveness. To impact this significant health problem, researchers must definitively ascertain the mechanisms by which viruses induce airway reactivity and must develop rational, safe approaches to prevent the consequences of viral infection in the patient with asthma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10608419     DOI: 10.1097/00063198-200001000-00003

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  4 in total

1.  IL-4 confers resistance to IL-27-mediated suppression on CD4+ T cells by impairing signal transducer and activator of transcription 1 signaling.

Authors:  Zhihong Chen; Shanze Wang; Nkiruka Erekosima; Yapeng Li; Jessie Hong; Xiaopeng Qi; Patricia Merkel; Vijaya Nagabhushanam; Eugene Choo; Rohit Katial; Rafeul Alam; Anita Trikha; Hong Wei Chu; Yonghua Zhuang; Meiling Jin; Chunxue Bai; Hua Huang
Journal:  J Allergy Clin Immunol       Date:  2013-08-16       Impact factor: 10.793

Review 2.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

3.  Antibiotics for asthma?

Authors:  Tina V Hartert; Kathryn Edwards
Journal:  Clin Infect Dis       Date:  2004-04-29       Impact factor: 9.079

Review 4.  Respiratory infections and asthma.

Authors:  Girolamo Pelaia; Alessandro Vatrella; Luca Gallelli; Teresa Renda; Mario Cazzola; Rosario Maselli; Serafino A Marsico
Journal:  Respir Med       Date:  2005-11-09       Impact factor: 3.415

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.